StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Eli Lilly & Co. (LLY) said one of its antibody therapies could be authorized for COVID-19 treatment as early as September - Reuters
June 10, 2020 3:40 PM
Eli Lilly & Co. (NYSE ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
FDA
Trader Talk